Efficiency Analysis of Pharmaceutical Companies in Pakistan: A Case Study of Ten Famous Companies
DOI:
https://doi.org/10.52131/pjhss.2023.1103.0708Keywords:
Pharmaceutical companies, DEA Methodology, Total Assets, Liabilities, Equity, Salaries, Wages, Earning Per Share, Dividend Per Shares, Return on EquityAbstract
Pharmaceutical companies contribute a remarkable amount to the Gross Domestic Product (GDP), employment, and poverty reduction. Pakistan has a very dynamic and reforming Pharmaceutical Industry. Around 759 pharmaceutical companies are operating in Pakistan. However, the study selected 10 leading pharmaceutical companies as a sample. Data Envelopment Analysis (DEA) was applied to analyse the efficiency of Pharmaceutical companies in selecting Total Assets, Liabilities, Equity, Salaries, Wages and other benefits, Sales, Earning Per Share (EPS), Dividend Per Share (DPS), and Return on Equity (ROE). The study ranked the pharmaceutical companies about the optimum utilization of input resources and to maximize the output that provides a guideline to other pharmaceutical companies to increase their revenues by improving their resource utilization following the leading companies’ models. Moreover, adopting the same strategy in figuring out ways to increase their efficiencies. This increase in efficiency will make the entire industry better off. It will also increase the GDP of the country.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Madiha Riaz, Syed Mumtaz Ali Kazmi, Muhammad Shahid Iqbal, Altaf Hussain
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.